Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.8%

3 terminated out of 63 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

27%

17 trials in Phase 3/4

Results Transparency

23%

9 of 39 completed with results

Key Signals

9 with results93% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (15)
P 1 (4)
P 2 (4)
P 3 (8)
P 4 (9)

Trial Status

Completed39
Unknown15
Withdrawn5
Terminated3
Recruiting1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (63)

Showing 20 of 20 trials
NCT01280825Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

NCT04356950Completed

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

NCT06025552Phase 1Completed

Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects

NCT01221389Phase 4Withdrawn

Study Using Plasma for Patients Requiring Emergency Surgery

NCT05353673Phase 2Unknown

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

NCT02637427Phase 3CompletedPrimary

Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures

NCT04762550Unknown

Thrombin Generation in Liver Transplant Surgery

NCT00127543Not ApplicableWithdrawn

Kid Cards: Teaching Kids About Medicines

NCT02776566Not ApplicableCompleted

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

NCT02856789CompletedPrimary

Determination of Fibrin Activity in Plasma on STA-R® Prototype

NCT02813538Completed

Major Liver Resection: Early Clotting Disorders and Functional Impairment.

NCT01787552Phase 1Completed

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

NCT02083549CompletedPrimary

Evaluating URMC's Massive Transfusion Protocol

NCT02972684Not ApplicableCompleted

Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass

NCT00964353Phase 4CompletedPrimary

Clinical and Economic Implications of Genetic Testing for Warfarin Management

NCT02918045Not ApplicableCompletedPrimary

Dental Extractions in Patients Under Dual Antiplatelet Therapy

NCT02086682Completed

A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients

NCT01604083Completed

European Transfusion Practice and Outcome Study

NCT03884725Phase 4Unknown

Fibrinogen Concentrate In Children Cardiac Surgery 2

NCT03882593UnknownPrimary

Blood Cell Adhesion to Arterial Filters During Cardiac Surgery

Scroll to load more

Research Network

Activity Timeline